Current perspectives in the pharmacopsychiatry of depression and mania.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Neuropharmacology

• Publication date

  1983-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0028-3908(83)90187-9PMID 6304556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of sodium valproate on mania

  2004cited by this paper
• On the mode of action of imipramine: relationship between serotonergic axon terminal function and down-regulation of beta-adrenergic receptors.

  1983cited by this paper
• β‐ENDORPHIN IMMUNOREACTIVITY IN THE PLASMA OF PSYCHIATRIC PATIENTS RECEIVING ELECTROCONVULSIVE TREATMENT *

  1982cited by this paper
• beta-Endorphin studies in psychiatric patients.

  1981cited by this paper
• Aversive effects of naltrexone in subjects not dependent on opiates.

  1981cited by this paper
• Buprenorphine in postoperative pain: results in 7500 patients

  1980cited by this paper
• Deficient prolactin response to morphine in depressed patients.

  1980cited by this paper
• Carbamazepine in manic-depressive illness: a new treatment.

  1980cited by this paper
• Action of Propranolol in Mania: Comparison of Effects of the d- and the l-stereoisomer

  1979cited by this paper
• β-Endorphin-Like Immunoreactivity in Cerebrospinal Fluid and Plasma of Patients with Schizophrenia and Other Neuropsychiatric Disorders

  1979cited by this paper
• beta-Endorphin-like immunoreactivity in cerebrospinal fluid and plasma of patients with schizophrenia and other neuropsychiatric disorders.

  1979cited by this paper
• Preliminary results of treatment with β-endorphin in depression

  1979cited by this paper
• The opiate receptor and morphine-like peptides in the brain.

  1978cited by this paper
• [The possibility of endorphins playing a role in psychic disturbances].

  1978cited by this paper
• The opiate receptor and morphine-like peptides in the brain

  1978cited by this paper
• gamma-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia.

  1977cited by this paper
• Beta-endorphin--induced changes in schizophrenic and depressed patients.

  1977cited by this paper
• gamma-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia.

  1977cited by this paper
• β-Endorphin-Induced Changes in Schizophrenic and Depressed Patients

  1977cited by this paper
• Increased CSF levels of endorphines in chronic psychosis.

  1976cited by this paper
• Brain receptors for antipsychotic drugs and dopamine: direct binding assays.

  1975cited by this paper
• Identification of two related pentapeptides from the brain with potent opiate agonist activity

  1975cited by this paper
• Anti‐Manic and Prophylactic Effects of Carbamazepine (Tegretol) on Manic Depressive Psychosis A Preliminary Report

  1973cited by this paper
• Further studies with propranolol in psychotic patients

  1972cited by this paper
• Clinical antidepressant activity of cyclazocine—a narcotic antagonist

  1970cited by this paper

• Evidence of alterations of Beta-endorphin levels and Mu-opioid receptor gene expression in bipolar disorder.

  2022cites this paper
• Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder

  2022cites this paper
• In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor

  2013cites this paper
• Anticonvulsants Used in Child and Adolescent Psychiatric Disorders

  2012cites this paper
• Announced reward counteracts the effects of chronic social stress on anticipatory behavior and hippocampal synaptic plasticity in rats

  2009cites this paper
• Experimentally induced aggressiveness in heroin-dependent patients treated with buprenorphine: comparison of patients receiving methadone and healthy subjects.

  2007cites this paper
• Naltrexone and buprenorphine combination in the treatment of opioid dependence

  2006cites this paper
• Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study.

  2006cites this paper
• Announced rewards counteract the impairment of anticipatory behaviour in socially stressed rats.

  2005cites this paper
• Induction of patients with moderately severe methadone dependence onto buprenorphine

  2005cites this paper
• Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome.

  2004cites this paper
• Adjunctive oxcarbazepine in comorbid anxiety and affective disorder with hyponatremic seizure: case analysis and literature review.

  2003cites this paper
• TOOLS TO MEASURE AND IMPROVE WELFARE OF LABORATORY RATS: REWARD-RELATED BEHAVIOUR AND ENVIRONMENTAL ENRICHMENT

  2003cites this paper
• Maintenance Efficacy of Divalproex in the Prevention of Bipolar Depression

  2003cites this paper
• HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS

  2002cites this paper
• Oxcarbapezine: anticonvulsant profile and safety.

  2001cites this paper
• [Calcium antagonists and lithium in preventive treatment of manic-depressive disorder].

  1996cites this paper
• The effects of valproate in brain monoamines of juvenile rats after stress.

  1993cites this paper
• Valproate in the Treatment of Bipolar Disorder: Literature Review and Clinical Guidelines

  1992cites this paper
• NIMH workshop report on treatment of bipolar disorder.

  1990cites this paper
• Initial human safety and tolerance study of a GABA uptake inhibitor, Cl‐966: Potential role of GABA as a mediator in the pathogenesis of schizophrenia and mania

  1990cites this paper
• Valproate use in acute mania and bipolar disorder: an international perspective.

  1989cites this paper
• Long-term use of valproate in primary psychiatric disorders.

  1989cites this paper
• Valproate in psychiatric disorders: literature review and clinical guidelines.

  1989cites this paper
• Handbook of Psychopharmacology

  1987cites this paper
• The Behavioral Effects of Opiates

  1987cites this paper
• Sodium Valproate: Its Use in Primary Psychiatric Disorders

  1987cites this paper
• GABA and circadian timekeeping: implications for manic-depression and sleep disorders.

  1986cites this paper
• Lithium mechanisms in bipolar illness and altered intracellular calcium functions.

  1986cites this paper
• Tierexperimentelle neurophysiologische Untersuchungen zur Lithiumwirkung

  1986cites this paper
• Electroacupuncture: an alternative to antidepressants for treating affective diseases?

  1986cites this paper
• Buprenorphine as new treatment for heroin dependence.

  1985cites this paper
• [Anxiolytic action of sodium valproate (possible role of gamma-aminobutyric acid in affective disorders)].

  1985cites this paper
• [Lithium valproate: its neuropharmacological spectrum and effect on transmitter amino acid content of the brain of rats].

  1984cites this paper